BioLineRx

BLRXNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$12.025 M

$2.48 -0.28%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

2,610,814,390

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#420Aspire BiopharmaASBP$12.2M
#421EnlivexENLV$12.1M
#422BioLineRxBLRX$12.0M
#423Kiora PharmaceuticalsKPRX$11.9M
#424Phio PharmaceuticalsPHIO$11.7M

What if BioLineRx were worth as much as…

Open the what-if tool →

Gold $30.3T

$6,243,372

Per share 2,517,489× higher

Bitcoin $1.72T

$354,672.48

Per share 143,013× higher

Nvidia $5.48T

$1,130,103

Per share 455,687× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for BioLineRx are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.